C
Market Data
$7.62−$1.28 (−14.38%)
CRVS · Last trade
Prev Close
$8.90
Range (30d)
$7.62 – $9.17
Recent Filings
- 8-K610.6 KBCorvus Pharmaceuticals, Inc.Dec 18, 7:30 AM ET·0001558370-24-016343
- 10-Q8.4 MBCorvus Pharmaceuticals, Inc.Nov 12, 4:03 PM ET·0001558370-24-015306
- 8-K291.0 KBCorvus Pharmaceuticals, Inc.Nov 12, 4:02 PM ET·0001171843-24-006284
- 8-K422.0 KBCorvus Pharmaceuticals, Inc.Oct 23, 4:11 PM ET·0001558370-24-013518
- 10-Q8.3 MBCorvus Pharmaceuticals, Inc.Aug 6, 4:02 PM ET·0001558370-24-011076
- 8-K544.0 KBCorvus Pharmaceuticals, Inc.Aug 6, 4:01 PM ET·0001171843-24-004479
- SC 13G/A130.8 KBCorvus Pharmaceuticals, Inc.Aug 1, 9:18 PM ET·0000919574-24-004203
- 8-K200.3 KBCorvus Pharmaceuticals, Inc.Jun 14, 4:15 PM ET·0001171843-24-003444
- SC 13G/A115.2 KBCorvus Pharmaceuticals, Inc.May 13, 4:52 PM ET·0000919574-24-002861
- SC 13G75.4 KBCorvus Pharmaceuticals, Inc.May 9, 5:29 PM ET·0000902664-24-003432
Insiders
10- ADAMS STREET PARTNERS LLC10% Owner
- Arcara JeffreyChief Business Officer
- CLARK IAN TDirector
- Gould Terry PDirector, 10% Owner
- Grais LindaDirector
- ISALY SAMUEL DDirector, 10% Owner
- Jones William BentonSee Remarks
- LEA LEIVChief Financial Officer
- MILLER RICHARD A MDDirector, President and CEO
- Morrison Scott WDirector
Tickers
Addresses
business
863 MITTEN ROAD SUITE 102
BURLINGAME, CA, 94010
mailing
863 MITTEN ROAD SUITE 102
BURLINGAME, CA, 94010